---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-026445"
form_type: "8-K"
ticker: "MIRA"
cik: "0001904286"
company_name: "MIRA PHARMACEUTICALS, INC."
filed_at: "2025-12-05T23:59:59+00:00"
generated_at: "2026-05-16T14:20:32.061364+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# MIRA Pharmaceuticals increases ATM offering capacity by $15.2M

## Summary
- Filed prospectus supplement to raise additional $15,241,591 via ATM offering.
- Previously sold $7,034,658 of common stock under same agreement with Rodman & Renshaw.
- Agreement dated August 12, 2024, amended September 24, 2024.

## SEC filing metadata
- accession: 0001493152-25-026445
- form_type: 8-K
- ticker: MIRA
- cik: 0001904286
- company_name: MIRA PHARMACEUTICALS, INC.
- filed_at: 2025-12-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1904286/000149315225026445/0001493152-25-026445-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1904286/000149315225026445/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-026445
- JSON: https://secwatch.observer/filing/0001493152-25-026445.json
- Plain text: https://secwatch.observer/filing/0001493152-25-026445.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.